Plus: BrightGene's oral dual agonist posts 8% weight loss at 8 weeks, Pinnacle Medicines raises $89M for oral peptides, and the NCI opens a tirzepatide oncology trial
As we discussed above we are careful in our progression to try to minimize side effects
Major medical sources note very limited research on lipotropic injections for weight loss, and that any weight change is often more attributable to the overall program (nutrition, activity, calorie intake) than the injection alone
Do not combine it with another GLP-1 medication unless specifically instructed by the prescriber
What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge Editorial Note This brief was updated on May 11, 2026 to reflect changes in the Trump administrations plans for implementation of the BALANCE Model in Medicare and an extension of the Medicare GLP-1 Bridge program through 2027
5-HTP may interact with serotonin-affecting medications (SSRIs, MAOIs)